BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 32393782)

  • 21. Mammalian target of rapamycin signaling in the podocyte.
    Inoki K; Huber TB
    Curr Opin Nephrol Hypertens; 2012 May; 21(3):251-7. PubMed ID: 22388550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Podocyte-specific GLUT4-deficient mice have fewer and larger podocytes and are protected from diabetic nephropathy.
    Guzman J; Jauregui AN; Merscher-Gomez S; Maiguel D; Muresan C; Mitrofanova A; Diez-Sampedro A; Szust J; Yoo TH; Villarreal R; Pedigo C; Molano RD; Johnson K; Kahn B; Hartleben B; Huber TB; Saha J; Burke GW; Abel ED; Brosius FC; Fornoni A
    Diabetes; 2014 Feb; 63(2):701-14. PubMed ID: 24101677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein tyrosine phosphatase 1B inhibition protects against podocyte injury and proteinuria.
    Kumagai T; Baldwin C; Aoudjit L; Nezvitsky L; Robins R; Jiang R; Takano T
    Am J Pathol; 2014 Aug; 184(8):2211-24. PubMed ID: 24951831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.
    Zhang H; Wang D; Li M; Plecitá-Hlavatá L; D'Alessandro A; Tauber J; Riddle S; Kumar S; Flockton A; McKeon BA; Frid MG; Reisz JA; Caruso P; El Kasmi KC; Ježek P; Morrell NW; Hu CJ; Stenmark KR
    Circulation; 2017 Dec; 136(25):2468-2485. PubMed ID: 28972001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin enhances metabolic capacities of cancer cells by dual regulation of glycolytic enzyme pyruvate kinase M2.
    Iqbal MA; Siddiqui FA; Gupta V; Chattopadhyay S; Gopinath P; Kumar B; Manvati S; Chaman N; Bamezai RN
    Mol Cancer; 2013 Jul; 12():72. PubMed ID: 23837608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resveratrol inhibits cancer cell metabolism by down regulating pyruvate kinase M2 via inhibition of mammalian target of rapamycin.
    Iqbal MA; Bamezai RN
    PLoS One; 2012; 7(5):e36764. PubMed ID: 22574221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells.
    Ebefors K; Wiener RJ; Yu L; Azeloglu EU; Yi Z; Jia F; Zhang W; Baron MH; He JC; Haraldsson B; Daehn I
    Kidney Int; 2019 Oct; 96(4):957-970. PubMed ID: 31402170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ability of remaining glomerular podocytes to adapt to the loss of their neighbours decreases with age.
    van der Wolde J; Haruhara K; Puelles VG; Nikolic-Paterson D; Bertram JF; Cullen-McEwen LA
    Cell Tissue Res; 2022 May; 388(2):439-451. PubMed ID: 35290515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury.
    Zhang L; Zhang Q; Liu S; Chen Y; Li R; Lin T; Yu C; Zhang H; Huang Z; Zhao X; Tan X; Li Z; Ye Z; Ma J; Zhang B; Wang W; Shi W; Liang X
    Kidney Int; 2017 Jul; 92(1):140-153. PubMed ID: 28318634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mTORC2/Akt/NFκB Pathway-Mediated Activation of TRPC6 Participates in Adriamycin-Induced Podocyte Apoptosis.
    Zhang HT; Wang WW; Ren LH; Zhao XX; Wang ZH; Zhuang DL; Bai YN
    Cell Physiol Biochem; 2016; 40(5):1079-1093. PubMed ID: 27960162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
    Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
    Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Ragulator in the Regulation of Mechanistic Target of Rapamycin Signaling in Podocytes and Glomerular Function.
    Yao Y; Wang J; Yoshida S; Nada S; Okada M; Inoki K
    J Am Soc Nephrol; 2016 Dec; 27(12):3653-3665. PubMed ID: 27032892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PKM2 Knockdown Induces Autophagic Cell Death via AKT/mTOR Pathway in Human Prostate Cancer Cells.
    Dey P; Kundu A; Sachan R; Park JH; Ahn MY; Yoon K; Lee J; Kim ND; Kim IS; Lee BM; Kim HS
    Cell Physiol Biochem; 2019; 52(6):1535-1552. PubMed ID: 31135122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
    Yang F; Qu Q; Zhao C; Liu X; Yang P; Li Z; Han L; Shi X
    Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
    Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
    Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GSK3β inactivation in podocytes results in decreased phosphorylation of p70S6K accompanied by cytoskeletal rearrangements and inhibited motility.
    George B; Vollenbröker B; Saleem MA; Huber TB; Pavenstädt H; Weide T
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1152-62. PubMed ID: 21228102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of C/EBP-α in Adriamycin-induced podocyte injury.
    Zhong F; Wang W; Lee K; He JC; Chen N
    Sci Rep; 2016 Sep; 6():33520. PubMed ID: 27644413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury.
    Yuan Y; Huang S; Wang W; Wang Y; Zhang P; Zhu C; Ding G; Liu B; Yang T; Zhang A
    Kidney Int; 2012 Oct; 82(7):771-89. PubMed ID: 22648295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.